(Q38241389)

31 August 2017

Management of hypertension and heart failure in patients with Addison's disease (English)

1 reference

31 August 2017

0 references

1

Warrick J Inder

1 reference

31 August 2017

3

Penny J Hunt

1 reference

31 August 2017

Caroline Meyer

2

1 reference

31 August 2017

16 September 2014

1 reference

31 August 2017

Clinical Endocrinology

1 reference

31 August 2017

82

1 reference

31 August 2017

6

1 reference

31 August 2017

789-792

1 reference

Cardiovascular risk factors in patients with Addison's disease: a comparative study of South African and Swedish patients.

31 August 2017

1 reference

Mineralocorticoids in the management of primary adrenocortical insufficiency

21 January 2018

1 reference

Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency.

21 January 2018

1 reference

How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids

21 January 2018

1 reference

Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study

21 January 2018

1 reference

Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome.

21 January 2018

1 reference

What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012?

21 January 2018

1 reference

Control of mineralocorticoid substitution in Addison's disease by plasma renin measurement

21 January 2018

1 reference

A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity

21 January 2018

1 reference

Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism

21 January 2018

1 reference

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials

21 January 2018

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

Fludrocortisone induced heart failure in Addison's disease

21 January 2018

1 reference

Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects

21 January 2018

1 reference

Aldosterone and cardiovascular disease: the heart of the matter

21 January 2018

1 reference

Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis

21 January 2018

1 reference

Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.

21 January 2018

1 reference

BNP in hormone-guided treatment of heart failure

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.12592

1 reference

31 August 2017

1 reference

PubMed ID

25138826